T83.713S Erosion of implanted urethral bulking agent to surrounding organ or tissue, sequela

Name of the Condition

• Erosion of implanted urethral bulking agent to surrounding organ or tissue, sequela

Summary

Erosion of implanted urethral bulking agent, sequela, refers to the residual effects or complications following the erosion of a urethral bulking agent into surrounding tissues or organs. This condition may result in persistent tissue damage, functional issues, or ongoing symptoms that require long-term management.

Causes

The sequela of erosion typically arises from prior erosion events, where the bulking agent has already worn through or into adjacent structures. Contributing factors may include incomplete healing, chronic inflammation, or the body's persistent reaction to the foreign material.

Risk Factors

• Prior history of urethral bulking agent erosion
• Chronic inflammation or infection at the implant site
• Impaired tissue healing (e.g., due to comorbidities or medications)
• Ongoing physical stress on the affected area
• Individual sensitivity to the implanted material

Symptoms

• Persistent pain or discomfort at the implant site
• Abnormal discharge or bleeding
• Recurrent urinary symptoms (e.g., incontinence, urgency)
• Signs of tissue exposure or damage
• Infection-related symptoms (e.g., fever, redness)

Diagnosis

Diagnosis involves evaluating the history of prior erosion and assessing current symptoms. Physical examination and imaging studies (e.g., ultrasound, MRI) may be used to determine the extent of residual tissue involvement. Additional procedures, such as cystoscopy, might be performed for detailed assessment.

Treatment Options

Treatment focuses on managing symptoms and addressing complications. This may include medications for pain or infection, surgical intervention to remove or repair affected tissues, or other interventions based on the severity of the sequela.

Prognosis and Follow-Up

Prognosis depends on the extent of tissue damage and response to treatment. Regular follow-up is often necessary to monitor for recurrence or new complications. Long-term management may be required to address persistent symptoms.

Complications

• Chronic pain or discomfort
• Recurrent infections
• Persistent urinary dysfunction
• Tissue damage requiring further surgery
• Delayed healing or scarring

Lifestyle & Prevention

• Avoid activities that place stress on the implant site
• Maintain good hygiene to reduce infection risk
• Follow post-procedure care instructions
• Report new or worsening symptoms promptly

When to Seek Professional Help

Seek medical attention if you experience increasing pain, signs of infection (e.g., fever, redness), abnormal discharge, or worsening urinary symptoms. Early evaluation can help prevent further complications.

Tips for Medical Coders

Use this code for encounters related to the sequela of urethral bulking agent erosion. Document the history of the erosion event and current manifestations to support coding. Ensure the code is not used for initial encounters or acute phases of erosion.